Diseases

T468X5S

Adverse effect of antivaricose drugs, including sclerosing agents, sequela

T468X5D

Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter

T375X5A

Adverse effect of antiviral drugs, initial encounter

T375X5S

Adverse effect of antiviral drugs, sequela

T375X5D

Adverse effect of antiviral drugs, subsequent encounter

T505X5A

Adverse effect of appetite depressants, initial encounter

T505X5S

Adverse effect of appetite depressants, sequela

T505X5D

Adverse effect of appetite depressants, subsequent encounter

T39015A

Adverse effect of aspirin, initial encounter

T39015S

Adverse effect of aspirin, sequela

T39015D

Adverse effect of aspirin, subsequent encounter

T423X5A

Adverse effect of barbiturates, initial encounter

T423X5S

Adverse effect of barbiturates, sequela

T423X5D

Adverse effect of barbiturates, subsequent encounter

T424X5A

Adverse effect of benzodiazepines, initial encounter

T424X5S

Adverse effect of benzodiazepines, sequela

T424X5D

Adverse effect of benzodiazepines, subsequent encounter

T447X5A

Adverse effect of beta-adrenoreceptor antagonists, initial encounter

T447X5S

Adverse effect of beta-adrenoreceptor antagonists, sequela

T447X5D

Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter

T434X5A

Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter

T434X5S

Adverse effect of butyrophenone and thiothixene neuroleptics, sequela

T434X5D

Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter

T43615A

Adverse effect of caffeine, initial encounter

T43615S

Adverse effect of caffeine, sequela

T43615D

Adverse effect of caffeine, subsequent encounter

T461X5A

Adverse effect of calcium-channel blockers, initial encounter

T461X5S

Adverse effect of calcium-channel blockers, sequela

T461X5D

Adverse effect of calcium-channel blockers, subsequent encounter

T40715A

Adverse effect of cannabis, initial encounter

T40715S

Adverse effect of cannabis, sequela

T40715D

Adverse effect of cannabis, subsequent encounter

T502X5A

Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter

T502X5S

Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela

T502X5D

Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter

T460X5A

Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter

T460X5S

Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela

T460X5D

Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter

T448X5A

Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter

T448X5S

Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela

T448X5D

Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter

T361X5A

Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter

T361X5S

Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela

T361X5D

Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter

T362X5A

Adverse effect of chloramphenicol group, initial encounter

T362X5S

Adverse effect of chloramphenicol group, sequela

T362X5D

Adverse effect of chloramphenicol group, subsequent encounter

T405X5A

Adverse effect of cocaine, initial encounter

T405X5S

Adverse effect of cocaine, sequela

T405X5D

Adverse effect of cocaine, subsequent encounter

T463X5A

Adverse effect of coronary vasodilators, initial encounter

T463X5S

Adverse effect of coronary vasodilators, sequela

T463X5D

Adverse effect of coronary vasodilators, subsequent encounter

T497X5A

Adverse effect of dental drugs, topically applied, initial encounter

T497X5S

Adverse effect of dental drugs, topically applied, sequela

T497X5D

Adverse effect of dental drugs, topically applied, subsequent encounter

T508X5A

Adverse effect of diagnostic agents, initial encounter

T508X5S

Adverse effect of diagnostic agents, sequela

T508X5D

Adverse effect of diagnostic agents, subsequent encounter

T475X5A

Adverse effect of digestants, initial encounter

T475X5S

Adverse effect of digestants, sequela

T475X5D

Adverse effect of digestants, subsequent encounter

T504X5A

Adverse effect of drugs affecting uric acid metabolism, initial encounter

T504X5S

Adverse effect of drugs affecting uric acid metabolism, sequela

T504X5D

Adverse effect of drugs affecting uric acid metabolism, subsequent encounter

T503X5A

Adverse effect of electrolytic, caloric and water-balance agents, initial encounter

T503X5S

Adverse effect of electrolytic, caloric and water-balance agents, sequela

T503X5D

Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter

T477X5A

Adverse effect of emetics, initial encounter

T477X5S

Adverse effect of emetics, sequela

T477X5D

Adverse effect of emetics, subsequent encounter

T493X5A

Adverse effect of emollients, demulcents and protectants, initial encounter

T493X5S

Adverse effect of emollients, demulcents and protectants, sequela

T493X5D

Adverse effect of emollients, demulcents and protectants, subsequent encounter

T453X5A

Adverse effect of enzymes, initial encounter

T453X5S

Adverse effect of enzymes, sequela

T453X5D

Adverse effect of enzymes, subsequent encounter

T484X5A

Adverse effect of expectorants, initial encounter

T484X5S

Adverse effect of expectorants, sequela

T484X5D

Adverse effect of expectorants, subsequent encounter

T40415A

Adverse effect of fentanyl or fentanyl analogs, initial encounter

T40415S

Adverse effect of fentanyl or fentanyl analogs, sequela

T40415D

Adverse effect of fentanyl or fentanyl analogs, subsequent encounter

T36AX5A

Adverse effect of fluoroquinolone antibiotics, initial encounter

T36AX5S

Adverse effect of fluoroquinolone antibiotics, sequela

T36AX5D

Adverse effect of fluoroquinolone antibiotics, subsequent encounter

T442X5A

Adverse effect of ganglionic blocking drugs, initial encounter

T442X5S

Adverse effect of ganglionic blocking drugs, sequela

T442X5D

Adverse effect of ganglionic blocking drugs, subsequent encounter

T380X5A

Adverse effect of glucocorticoids and synthetic analogues, initial encounter

T380X5S

Adverse effect of glucocorticoids and synthetic analogues, sequela

T380X5D

Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter

T45625A

Adverse effect of hemostatic drug, initial encounter

T45625S

Adverse effect of hemostatic drug, sequela

T45625D

Adverse effect of hemostatic drug, subsequent encounter

T470X5A

Adverse effect of histamine H2-receptor blockers, initial encounter

T470X5S

Adverse effect of histamine H2-receptor blockers, sequela

T470X5D

Adverse effect of histamine H2-receptor blockers, subsequent encounter

T420X5A

Adverse effect of hydantoin derivatives, initial encounter

T420X5S

Adverse effect of hydantoin derivatives, sequela